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Sympathetic Innervation of Lymphoreticular Organs
Is Rate Limiting for Prion Neuroinvasion
tional axonal transport (Glatzel and Aguzzi, 2000b; Hain-
fellner and Budka, 1999) and may involve PrPSc-specific
binding proteins (Fischer et al., 2000). Upon intraperito-
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sidering that lymphoid organs are predominantly inner-
vated by sympathetic nerve fibers, the SNS seems to
be a prime target for transport and perhaps also forSummary
replication of the prion agent (Felten and Felten, 1988).
Lymphoid organs, including the spleen, are early sitesTransmissible spongiform encephalopathies are com-
monly propagated by extracerebral inoculation of the of accumulation and replication of the agent following
i.p. inoculation (Eklund et al., 1967; Kimberlin andinfectious agent. Indirect evidence suggests that entry
into the central nervous system occurs via the periph- Walker, 1989). Ablation of B cells suppresses prion neu-
roinvasion (Klein et al., 1997, 1998), probably becauseeral nervous system. Here we have investigated the
role of the sympathetic nervous system in prion neu- B cells transmit a lymphotoxin--dependent signal to
follicular dendritic cells (FDCs) (Montrasio et al., 2000),roinvasion. Following intraperitoneal prion inocula-
tion, chemical or immunological sympathectomy de- which are a prominent site of PrPSc deposition (Kitamoto
et al., 1991).layed or prevented scrapie. Prion titers in spinal cords
were drastically reduced at early time points after in- In order to study the role of the SNS in neuroinvasion,
we sympathectomized mice using three different proto-oculation. Instead, keratin 14-NGF transgenic mice,
whose lymphoid organs are hyperinnervated by sym- cols. Permanent sympathectomy was performed by in-
jecting 6-hydroxydopamine (6-OHDA), or anti-nerve-pathetic nerves, showed reduction in scrapie incuba-
tion time and, unexpectedly, much higher titers of growth factor antibodies (anti-NGFAb), into newborn
mice. Transient sympathectomy was achieved by ad-prion infectivity in spleens. We conclude that sympa-
thetic innervation of lymphoid organs is rate limiting ministering 6-OHDA over a period of 7 weeks to 8- to
10-week-old mice. All of these methods cause efficientfor prion neuroinvasion and that splenic sympathetic
nerves may act as extracerebral prion reservoirs. and protracted sympathectomy (Picklo, 1997). We found
that permanent and transient sympathectomy signifi-
cantly delayed, or even prevented, development of ter-Introduction
minal scrapie upon i.p. inoculation of the infectious
agent.Prion diseases are fatal neurodegenerative diseases of
humans and animals. The infectious agent is termed The role of the SNS was further investigated with
transgenic mice overexpressing nerve growth factorprion (Aguzzi and Weissmann, 1997) and is thought to
be identical with PrPSc, a protease-resistant conformer that show massive sympathetic hyperinnervation of
lymphoid organs (Carlson et al., 1995). The incubationof the cellular protein PrPC (Prusiner, 1982). Although
prions are most efficiently propagated through intrace- time of scrapie following i.p. inoculation of prions was
significantly reduced when compared to nontransgenicrebral inoculation, peripheral infection is the natural
route of transmission in most prion diseases. Kuru, BSE, control mice. Surprisingly, hyperinnervated spleens
contain 100 fold more infectivity, suggesting thatand the new variant of Creutzfeldt-Jakob disease are
caused by oral uptake of the infectious agent, while splenic nerve endings may act as prion reservoirs.
parenteral administration of growth hormone and go-
nadotropins has resulted in iatrogenic Creutzfeldt- Results
Jakob disease (Glatzel and Aguzzi, 2000a).
The pathways by which prions invade the central ner- Efficient and Specific Sympathectomy Using
vous system (CNS) are only partially understood. A large 6-OHDA or a Monoclonal Anti-NGF Antibody
body of evidence indicates that both the lymphoreticular Selective sympathectomy was performed by adminis-
system (LRS) and peripheral nerves are involved in tering 6-OHDA or anti-NGFAb to wild-type mice. All
scrapie neuroinvasion (Klein et al., 1997; Lasmezas et methods induced significant, but not complete deple-
al., 1996; Race et al., 2000). The mode of transport of tion of sympathetic nerves as assessed by Western blot
infectivity in peripheral nerves has not been determined analysis (Figure 1A) and by immunohistochemical stains
yet. Recent studies point to the possibility that the infec- of spleens (Figure 1B) for tyrosine hydroxylase (TH), a
tious agent utilizes mechanisms distinct from conven- marker of sympathetic nerves innervating lymphoid or-
gans. There was no significant difference in the distribu-
tion and amount of FDCs between sympathectomized3 Correspondence: adriano@pathol.unizh.ch
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Figure 1. Effects of 6-OHDA-Induced Dener-
vation and of K14NGF-Induced Hyperinner-
vation on Mouse Spleens
(A) Western blot analysis of TH in spleens of
adult 6-OHDA-treated mice, K14NGF trans-
genic mice, and controls. The two main TH
bands, visible at ca. 55 kDa, were stronger
in older mice (after four injections and later),
consistent with the increase in sympathetic
innervation with age. Lower panel: quantifica-
tion of TH content by chemiluminescence
scanning. Bars represent the ratio between
signal intensity of the TH band and that of the
corresponding -actin bands (arbitrary units).
(B) Confocal immunofluorescence analysis of
control (NaCl-treated), denervated (6-OHDA-
treated), and hyperinnervated K14NGF spleens.
Sympathetic nerves (displayed in black) are
visualized with anti-TH antibodies. Sympathetic
innervation was mainly localized around ves-
sels (arrows), although some nerve fibers pro-
trude in the splenic parenchyma (asterisk).
6-OHDA-treated spleens contained only sin-
gle occasional fibers, while hyperinnervated
spleens showed abundant nerve fibers around
vessels and in the splenic parenchyma.
(C) Spleen sections of NaCl-injected and
6-OHDA-injected mice immunostained with
the FDC-specific antibody FDC-M1 showed
no difference in the topography and size of
FDCs as assessed by morphometry (right-
most panel). Bars represent the area occu-
pied by the FDC signal (in 1000 m2 per ten
high-power fields).
(n 6) and control mice (n 3) as analyzed by immuno- lenged with various doses of prions. The effect was
more pronounced when permanent denervation washistochemical staining with antibody FDC-M1 to FDCs
(Figure 1C). To rule out any putative impairment of im- performed by administering 6-OHDA or anti-NGFAb
neonatally (Figure 3B). In these groups, the mean incu-mune cells in sympathectomized mice, blood and
spleens before and after 6-OHDA injections were ana- bation times until the onset of terminal scrapie were
244 20 days (105LD50 units, n 7) for 6-OHDA-treatedlyzed for the presence and total numbers of blood cells
utilizing a hemocytometer and fluorescence-activated mice and 254  18 days (104 LD50 units, n  6) for anti-
NGFAb-treated mice. One mouse was sacrificed at daycell sorting (FACS). There was no change in blood and
splenic CD4and CD8T lymphocytes (data not shown). 288 because of wasting and did not show histopatholog-
ical signs of scrapie (Figures 4I and 4J). Untreated miceWe detected a slight increase in CD11b leukocytes
and B220/CD45R B lymphocytes in peripheral blood developed terminal scrapie disease after 189  4 days
(105 LD50 units, n  4) and 214  1 days (104 LD50 units,and spleens. After the first injection of 6-OHDA, FACS
analysis evidenced a higher amount of leukocytes with n  4) (Figure 3B).
Incubation times for mice denervated as adults werea relative decrease in B lymphocytes within a measured
population of 10,000 cells (Figure 2). Total numbers of 220  4 days (106 LD50 units, n  7) and 279  25 days
(103 LD50 units, n  5) (Figure 3A). One mouse had to belymphocytes and leukocytes in peripheral blood, as de-
termined by hemocytometer, showed mild increase in taken at day 292 because of wasting and did not show
histopathological signs of scrapie or accumulation ofCD11b cells and a minor increase in lymphocytes (data
not shown). PrPSc in brain or spleen (Figure 5A). The respective con-
trol groups developed terminal scrapie disease after
237  3 days (103 LD50 units, n  5) and 184  9 daysSympathectomy Delays Development of Scrapie
Following Peripheral Prion Administration (106 LD50 units, n  5) (Figure 3A). None of the mock-
inoculated control mice developed neurological dis-Sympathectomized mice display significant prolonga-
tion of incubation times until terminal scrapie when chal- ease. These mice were sacrificed at day 288 (n  4 for
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Figure 2. FACS Analysis of Peripheral Blood and Spleen Cells at Various Time Points after Injection of 6-OHDA or of Vector
Density plots of the relative frequencies (indicated in percentages of 10,000 cells) of B220/CD45R B lymphocytes (vertical axis) and CD11b
leukocytes (horizontal axis). A slight rise in CD11b cells and a relative decrease in B220/CD45R B lymphocytes were evident after the first
injection of 6-OHDA in peripheral blood and in spleen, yet both populations returned to normal levels after additional injections.
the anti-NGFAb group) or died of unrelated causes after between vagal and nonvagal brain stem nuclei of dener-
vated mice (Figure 7). Therefore, we could not find anyday 360 (n  5 for the 6-OHDA-treated group).
It has been reported that peripheral administration of evidence that vagal spread of prions substitutes for sym-
pathetic spread in sympathectomized mice.6-OHDA or of anti-NGFAb does not affect the synthesis
or metabolism of TH in the CNS (Picklo, 1997). To deter-
mine whether the same is true for the expression and Reduced Scrapie Pathology and Prion Replication
processing of PrPC, we performed quantitative Western in Spinal Cords of Sympathectomized Mice 90
blot analyses for PrPC on CNS tissue samples of dener- Days after Prion Administration
vated and control mice. There was no alteration in the To confirm that elimination of the SNS affects transport
amount of PrPC or in the glycosylation pattern of PrPC from lymphoid organs to the CNS, we studied the mor-
between the two groups (Figure 6). This indicates that phology and prion titers of spinal cords 90 days after i.p.
the delay in incubation times of sympathectomized mice inoculation with scrapie prions. We focused on thoracic
is not due to downregulation of PrPC in the CNS. segments 7–9 because it was shown that the first patho-
logical changes and replication of infectivity occur in
this region (Cole and Kimberlin, 1985). Transiently sym-No Evidence for Neuroinvasion via Vagal Nerve
in Sympathectomized and in Control Mice pathectomized mice (n  6) showed significantly less
gliosis and spongiosis when compared to the controlUpon oral challenge, prions appear to spread via the
vagal nerve (Baldauf et al., 1997; Beekes et al., 1998). mice (n  4) (Figures 4A and 4B). Surprisingly, no PrPSc
could be detected in any of the sympathectomized orIn order to investigate the utilization of this route, we
analyzed the dorsal motor nucleus of the vagal nerve in control mice by histoblot and Western blot (data not
shown). We determined prion titers in two thoracic spinalsympathectomized mice. However, the degree of gliosis
and spongiosis did not vary between scrapie-sick de- cord segments of treated and untreated mice using the
incubation time assay (Prusiner et al., 1982) calibratednervated (n  8) and nondenervated mice (n  6), or
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Figure 3. Survival Plots Displaying the Incubation Time (Days) until Development of Terminal Scrapie in C57BL/6 Mice Inoculated i.p. with
Prions and of tga20 Indicator Mice Inoculated i.c. with Spinal Cord and Spleen Samples
(A–C) Mice injected with 6-OHDA in their adulthood (A), as well as mice injected neonatally with anti-NGF antibodies or with 6-OHDA (B)
developed terminal scrapie significantly later than their respective controls. Instead K14NGF mice, which have hyperinnervated spleens,
developed terminal scrapie earlier than matched wild-type siblings of the same genetic background (C). The size of inoculum is expressed
in logLD50 units.
(D) Prion titers (right bar) as calculated by the incubation time (left bar) method. Tested samples (as indicated) were taken at different time
points (upper horizontal bar). Diamonds indicate individual mice. Small horizontal bars indicate average incubation time. Spinal cords from
6-OHDA-treated mice showed very low or undetectable levels of prion infectivity. Spleens of hyperinnervated K14NGF transgenic mice
displayed titers of infectivity that were at least two logs higher than those of wild-type mice.
Prion Neuroinvasion and Sympathetic Nerves
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Figure 4. Histopathological Findings in Spinal Cords (Level 7–9) and Hippocampi of Mice Sacrificed after Prion Inoculation
Prominent spongiosis (C, E, and G) and gliosis (B, D, F, and H) are visible in spinal cords (left column) and hippocampi (all other columns) of
terminally sick mice. Spinal cords of 6-OHDA-injected mice showed no detectable gliosis (A). One of the neonatally anti-NGFAb-injected mice
showed no spongiosis (I) nor gliosis nor scrapie symptoms when sacrificed 288 days after inoculation (J), potentially indicating complete
protection from scrapie.
with tga20 indicator mice (Brandner et al., 1996). As 4.9 logLD50  mg1 for K14NGF, 2.7, 2.6 logLD50  mg1
for controls) (Figure 3D).expected, prion titers of spinal cords from untreated
mice were high (4.1 logLD50  mg1 and 4.9 logLD50 
mg1), whereas spinal cords from sympathectomized K14NGF Mice Do Not Show
mice did not contain detectable infectious prions (	0 Immunological Alterations
logLD50  mg1) (Figure 3D). Since the immune system plays a key role in prion patho-
genesis, we investigated salient immune parameters in
K14NGF mice. FACS analysis of spleen and blood using
Incubation Times of Sympathectomized
a range of monoclonal antibodies directed against B
and Control Mice Are Unchanged Following
cells, T cells, their subsets, and macrophages did not
Intracerebral Inoculation with Prions
reveal any immune system alterations in K14NGF mice
In order to rule out any unspecific effects of 6-OHDA
(data not shown). These results are consistent with pre-
on the development of scrapie, we inoculated transiently
vious studies in which functional immunological assays
6-OHDA-treated and control mice with prions intracere-
did not reveal differences between transgenic and wild-
brally. All inoculated mice developed scrapie symptoms
type mice (Carlson et al., 1997).
as expected. There was no significant difference in the
incubation time until development of terminal scrapie
Prion Titers in Spinal Cords of K14NGF Mice
symptoms. Incubation times for denervated mice were
Four K14NGF and three wild-type mice were sacrificed
175  2 days and 182  1 days for controls (both 3
50 days after i.p. inoculation. Western blot and histoblot
logLD50 units, n  3). analyses of spinal cords did not show accumulation of
PrPSc in any of the examined mice (Figure 6). Next we
determined prion titers in thoracic spinal cords (seg-K14NGF Mice Show Shortened Scrapie Incubation
ments 7–9) (n  3 for K14NGF, n  2 for controls). OneTimes and High Titers of Prion Infectivity
of the spinal cords taken from a K14NGF transgenicin Spleens
mouse showed a high prion titer (4.7 logLD50  mg1),If sympathetic innervation is a rate-limiting determinant
whereas titers from the other transmitted spinal cordsfor prion neuroinvasion, hyperinnervated mice should
displayed lower prion titers (3.8 logLD50  mg1 forshow a decrease in incubation times until the onset of
K14NGF and 3.2 logLD50  mg1 for control). In onescrapie disease. To test this prediction, we analyzed
spinal cord of the hyperinnervated and control mice, thescrapie pathogenesis in transgenic mice overexpressing
prion titer was below detection limit for the bioassay.NGF under transcriptional control of the keratin 14 pro-
moter, which develop massive hyperinnervation of lym-
phatic organs (Carlson et al., 1995) (Figures 1A and 1B). Discussion
Incubation times until development of terminal disease
after i.p. inoculation were 21 days shorter (209  15 Evidence that Sympathetic Innervation
of Lymphoreticular Organs Is Involveddays, n  12) for K14NGF mice than for wild-type mice
(230  9 days, n  6) (Figure 3C). Histoblots of spleens in Neuroinvasion
Peripheral challenge of mice with prions results in accu-showed considerably more accumulation of PrPSc in
spleens of K14NGF mice (Figures 5A and 5B). Surpris- mulation of the infectious agent in organs of the
lymphoid system at very early time points (Eklund et al.,ingly, splenic prion titers of hyperinnervated mice were
much higher than prion titers of wild-type mice (4.7, 4.9, 1967; Lasmezas et al., 1996). Prion transfer from the
Neuron
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Figure 5. Accumulation of PrPSc in Brains and Spleens of Mice Inoculated i.p. with Prions
(A) Histoblots showing immunoreactive PrPC in brains (left) and spleens (right) before (1st and 4th column) and after digestion (2nd, 3rd, 5th, and
6th column) with increasing concentrations of proteinase K. Mock-inoculated mice (6th row) show proteinase K-sensitive PrPC but no proteinase
K-resistant PrPSc in brains and spleens. One of the 6-OHDA-injected mice (euthanized at 294 days because of progressive ascites) did not
show any PrPSc in brain or spleen (1st row). Terminally sick mice showed proteinase K-sensitive PrPC and proteinase K-resistant PrPSc in brains
and spleens. However, accumulation of PrPSc in spleens of 6-OHDA- or anti-NGFAb-injected mice (rows 2 and 3) was not as strong as in wild-
type mice (row 4). The fifth row shows the pattern of PrPSc accumulation in a terminally sick K14NGF transgenic mouse. Note the intense
accumulation of PrPSc in this mouse compared to the wild-type control.
(B) Higher magnification of tissues showed in (A), demonstrating the difference in spleen PrP immunoreactivity after proteinase K digest of
terminally sick wild-type (left side) and hyperinnervated K14NGF transgenic mice (right side). This finding is paralleled by higher prion titers
in spleens of hyperinnervated mice (see Figure 3D).
(C) Western blot detection of PrPC and PrPSc. Left blot, brain; right blot, spleen. Proteinase K digest as indicated above each lane ( or ).
For controls, we analyzed terminally sick C57BL/6 mice (pos. cont.), mock injected C57BL/6 mice (neg. cont.), and Prnp knockout mice
(Prnpo/o). PrPSc was detectable in brains and spleens of all mice that presented with scrapie symptoms. The particularly strong signal in one
brain of a 6-OHDA-treated mouse (5th lane from left) is most likely the result of natural variations in the amount of proteinase-resistant prion
protein in terminally sick mice.
Prion Neuroinvasion and Sympathetic Nerves
31
Figure 6. Accumulation of PrPSc in Brains and
Spinal Cords of Control and Hyperinnervated
Mice
Western blot analysis of PrP in brains of
6-OHDA-treated, control mice and in spinal
cords (segments Th7–9) of K14NGF and of
wild-type mice euthanized 50 days after prion
administration. There were no alterations in
the extent or in the glycosylation pattern of
brain PrPC. No accumulation of PrPSc was de-
tectable in spinal cords of K14NGF and wild-
type mice at this early time point. Terminally
sick C57Bl/6 mice, mock injected C57Bl/6
mice, and Prnp knockout mice (Prnpo/o) were
used as controls. Plus and minus signs above
each lane indicate whether proteinase K di-
gest was performed.
lymphoid system to the CNS occurs most likely along
peripheral nerves in a PrPC-dependent fashion (Bla¨ttler
et al., 1997; Glatzel and Aguzzi, 2000b; Race et al., 2000).
Studies focusing on the temporal and spatial dynamics
of neuroinvasion have suggested that the autonomic
nervous system might be responsible for transport from
lymphoid organs to the CNS (Beekes et al., 1998; Clarke
and Kimberlin, 1984; Cole and Kimberlin, 1985; McBride
and Beekes, 1999). The innervation pattern of lymphoid
organs is mainly sympathetic (Felten and Felten, 1988).
To clarify the role of the SNS in neuroinvasion of pri-
ons, we depleted or enhanced sympathetic innervation
of lymphoid organs using various regimens. All three sym-
pathectomy protocols chosen, i.e., injection of 6-OHDA
in adult or in newborn mice or of anti-NGF antibodies
in newborn mice, were shown by histological and bio-
chemical methods to reduce the amount of noradrener-
gic nerve fibers substantially. Sympathetic denervation
significantly delayed the development of scrapie in all
experimental designs. In one mouse denervated by
6-OHDA injection and in one mouse of the anti-NGFAb
group, treatment blocked prion neuroinvasion com-
pletely and prevented all clinical signs of scrapie. A
detailed temporal breakup of infectivity titers in spinal
cords indicates that sympathectomy inhibited the trans-
port of prions from lymphatic organs to the thoracic
spinal cord, which is the entry site of sympathetic nerves
to the CNS (Figure 3D). We attempted to correlate these
findings with quantitative measurements of PrPSc in spi-
nal cords but were unable to detect PrPSc at 50–90 days
post inoculation. This is probably because biochemical
methods are several orders of magnitude less sensitive
than prion infectivity bioassays.
The importance of the SNS was further underscored
by the time to onset of clinical scrapie in transgenic mice
with sympathetic hyperinnervation of immune organs.
Hyperinnervated mice developed scrapie symptoms sig-
Figure 7. Histological Analysis of Brain Stems in Sympathecto- nificantly earlier than their nontransgenic controls.
mized Mice
(A–D) Dorsal motor nuclei of the vagal nerve (n.d.v., indicated as
red square in [F]). No Evidence for Direct Effects of Sympathetic
(E) Nucleus centralis medullae oblongatae (n.m.o., indicated as blue Denervation/Hyperinnervation
square in [F]). All mice were terminally scrapie-sick with the excep- on the Immune System
tion of (B). There is neither a difference in the degree of gliosis Because components of the immune system are neces-
between denervated (C and D) and nondenervated mice (A), nor
sary for accumulation of prions in lymphoid organs andbetween vagal and nonvagal brain stem nuclei of denervated mice
for transport of prions from peripheral sites to the CNS(C–E).
All sections were immunostained with a GFAP antiserum. (Klein et al., 1997; Lasmezas et al., 1996), we carefully
examined any effects that sympathectomy may have on
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the immune system. FACS analysis and blood cell counts ported within peripheral nerves. Axonal and nonaxonal
transport mechanisms may be involved, and nonneu-of B, T cells and leukocytes showed an initial phase
of mild activation, but soon returned to normal after ronal cells (such as Schwann cells) may play a role.
Within the framework of the protein-only hypothesis,sympathetic denervation. We attribute this activation
characterized by a slight increase in total numbers of one may hypothesize a “domino” mechanism, by which
incoming PrPSc converts resident PrPC on the axolemmalleukocytes and lymphocytes to an unspecific acute re-
sponse induced by 6-OHDA. No alteration in lymphocyte surface, thereby propagating spatially the infection.
While speculative, this model is attractive since it maysubpopulations was detected in spleens at any time
point investigated. Results from experimental models accommodate the finding that the velocity of neural
prion spread is extremely slow (Kimberlin et al., 1983)of sympathetic denervation have been conflicting,
showing enhancement (Madden et al., 1994; Kruszew- and may not follow the canonical mechanisms of fast
axonal transport. Indeed, recent studies may favor aska et al., 1995) or suppression (Kohm and Sanders,
1999) of the immune system. Our findings are in line nonaxonal transport mechanism that results in periaxo-
nal deposition of PrPSc (Glatzel and Aguzzi, 2000b; Hain-with a possibly enhanced immune response, albeit mod-
est and transient. fellner and Budka, 1999).
Our results are in agreement with previous studiesA wealth of evidence points to mature FDCs as the
sites of prion accumulation and replication in lymphoid showing that following peripheral administration of pri-
ons, the agent accumulates in sympathetic gangliaorgans (Kitamoto et al., 1991; Montrasio et al., 2000).
Therefore, we decided to quantify the amount of FDCs (McBride and Beekes, 1999), and the first pathological
lesions are observed in the gray matter of midthoracicin sympathectomized and control mice. We did not de-
tect any significant differences in the content of FDCs spinal cords. This corresponds to the entry site of the
splanchnic nerves in the CNS (Cole and Kimberlin, 1985).of treated and untreated mice, which is consistent with
findings from recent experiments (Kohm and Sanders,
1999) and negates the possibility that the effects ob- Sympathetic Neuroinvasion and Prophylaxis
served may be due to modulation of FDC microanatomy. of Prion Diseases
The fact that denervated mice eventually developed
Sympathetic Nerves and the Current Models scrapie may be due to (1) an alternative, low-efficiency
of Prion Neuroinvasion route of entry that may become uncovered by the ab-
Transport of prions from spleen to spinal cord was stud- sence of sympathetic fibers or (2) incomplete sympa-
ied by determining infectious titers of thoracic spinal thectomy. Entry through the vagal nerve has been pro-
cords and spleens 50 days after i.p. injection of prions. posed in studies of the dynamics of vacuolation
Only one out of four spinal cords of K14NGF mice following oral and i.p. challenge with prions (Baldauf et
showed a high prion titer, whereas the titers of the other al., 1997; Beekes et al., 1998). We therefore examined
transgenic spinal cords were comparable to the con- vacuolation and gliosis in brain stems of denervated
trols. This supports the view that elimination of sympa- and nondenervated mice. There was no evidence for
thetic nerves blocks entry into the CNS, while overex- transport along the vagal nerve in sympathectomized
pression of sympathetic nerves does not increase the mice, since vagal nuclei were affected similarly to other
velocity of transport in the peripheral nervous system. regions of the brain stem unrelated to the vagal system.
Instead hyperinnervation may augment the develop- This supports the hypothesis that delayed neuroinva-
ment of clinical scrapie by facilitating replication of in- sion in denervated mice may occur because of residual
fectious prions in the spleen, since prion titers in hyper- innervation of lymphoreticular organs.
innervated spleens were at least two logs higher than The surprising finding that infectious titers in hyperin-
prion titers in control spleens. nervated spleens are at least two logs higher and show
In the last several years, we have elaborated a model enhanced PrPSc accumulations in histoblots compared
that predicts prion neuroinvasion to consist of two dis- to control mice suggests that sympathetic nerves, be-
tinct phases (Aguzzi et al., 2001). In the first phase, sides being involved in the transport of prions, may also
widespread colonization of lymphoreticular organs is accumulate and replicate prions in lymphatic organs,
achieved by mechanisms that depend on B-lympho- as hypothesized earlier (Clarke and Kimberlin, 1984).
cytes (Klein et al., 1997, 1998), follicular dendritic cells The identification of the SNS as a rate-limiting compo-
(Montrasio et al., 2000), and complement factors (Klein nent in prion neuroinvasion also has a practical fallout:
et al., 2001). The second phase has long been suspected it suggests that pharmacological or genetic (Glatzel et
to involve peripheral nerves, and possibly the SNS, and al., 2000) manipulations of the SNS could be useful as
may depend on expression of PrPC by these nerves a novel therapeutical approach to delaying or preventing
(Glatzel and Aguzzi, 2000b). neuroinvasion.
While this study implies the SNS as a major compo-
nent of the second phase of prion neuroinvasion, many Experimental Procedures
details remain to be elucidated. In particular, it is not
Chemical Sympathectomyknown whether prions can be transferred directly from
For transient sympathectomy, female 8-week-old C57BL/6 miceFDCs to sympathetic endings, or whether additional cell
were injected i.p. with 6-OHDA (Sigma, 220 mg/g mouse weight)types are involved. The latter possibility is particularly
weekly in 0.8% NaCl containing 1 103 M ascorbate as antioxidant.
enticing since FDCs have not been shown to entertain Mice received seven weekly injections of 6-OHDA, while control
physical contact with SNS terminals. mice received ascorbate injections at the same time points. Mice
in the experimental groups were injected with infectious prions orMoreover, it is unclear how prions are actually trans-
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with mock inoculum 3 days after the first administration of 6-OHDA nizing tissues using a pellet mixer and by sonicating samples for 5
min with a Branson 450 sonifier at a constant output power of 400W.or ascorbate. For permanent sympathectomy, newborn C57BL/6
mice were injected with 6-OHDA (Sigma; 50 mg/g mouse weight) 30 l (diluted 1:10 in PBS and 1% BSA) was administered i.c. to
groups of three or four tga20 (Fischer et al., 1996) mice for eachon postnatal days 1–4, while control mice received ascorbate injec-
tions. Only female mice were included in the further study. At 8 sample. Incubation time until development of terminal scrapie sick-
ness was determined and infectivity titers were calculated for 1 mgweeks of age, mice in the experimental groups were injected i.p.
with prions or with mock inoculum. A total of 33 mice was included of inoculated tissue using the relationship y 11.45 0.088x, where
y is LD50 and x is the incubation time (days) to terminal diseasein the control group to study the degree of sympathetic denervation
and its effects on the immune system. These mice were injected (Brandner et al., 1996).
with 6-OHDA (n  21) or NaCl (n  12) at the same time points as
the experimental mice. Spleens and blood were assayed by FACS Western Blot Analysis
analysis, by Western blots for TH, and by immunostains for TH, 10% (w/v) homogenates of thoracic spinal cord (segments 7–9),
FDCs, and B and T cell markers (see below). brain, or spleen were prepared as described (Bu¨eler et al., 1993)
and, where indicated, digested with 20 g/ml proteinase K (PK) for
Immunological Sympathectomy 30 min at 37
C. 50 (for TH detection and brains) or 100 (for spleens)
Newborn C57BL/6 mice were injected with monoclonal anti-NGFAb g of total protein was electrophoresed through 12%-SDS poly-
(Roche, Switzerland, 7.5 g antibody/ injection dissolved in 150 l acrylamide gels and transferred to nitrocellulose membranes. Mem-
sterile water, whereas controls received sterile water injections) on branes were probed with monoclonal antibody 6H4 (for brain,
postnatal days 2, 3, and 10. Only female mice were included in the 1:5000, Prionics, Switzerland) or 1B3 (for spleen, 1:5000) (Farquhar
further study. At 8 weeks of age, mice in the experimental groups et al., 1996) to mouse PrPC, or with a monoclonal antibody to TH
were injected with infectious prions or with mock inoculum. The (1:5000, Sigma clone TH-2) and developed by enhanced chemilumi-
efficiency of sympathetic denervation was quantitated by immuno- nescence (Amersham). Quantification of TH expression was accom-
stains for TH (see below). plished by scanning membranes with a Kodak image station 440.
The signal intensities produced by spleens from control animals
Inoculation of Mice were measured and compared to the signal intensity of spleens
For all inoculations, we used dilutions of brain homogenate prepared from sympathectomized mice using 1D image analysis software
as described from mice infected with the Rocky Mountain Labora- (Kodak).
tory scrapie prions (RML, passage 4.1) (Bu¨eler et al., 1993). A total
of 66 mice were inoculated i.p. using 26G needles and 200 l syrin-
Histoblots
ges with dilutions of the brain homogenate (in PBS containing 5%
Histoblots were performed according to Taraboulos et al. (1992).
bovine serum albumin [BSA], 100 l inoculation volume). Six mice
Frozen sections were mounted on uncoated glass slides and imme-
were intracerebrally injected with the same inoculum using a similar
diately pressed on a nitrocellulose membrane wetted in lysis buffer.
needle and syringe (30 l inoculation volume). A total of nine mice
Membranes were air dried for at least 24 hr. For detection, they
were injected i.p. with mock inoculum consisting of brain homoge-
were rehydrated in Tris-buffered saline-Tween, and limited proteoly-
nate prepared similarly from uninfected mice. All mice were of the
sis was performed using proteinase K concentrations of 50 and 100
C57BL/6 inbred strain, except for K14NGF transgenic mice and their
g/ml at 37
C for 4 hr. Blots were then denatured in 3 M guanidinium
controls, which were C57BL/6-C3H hybrids .
thiocyanate for 10 min and blocked for 1 hr in 5% non-fat milk
serum. Incubation with primary antibody XN was carried out at a
Histological Studies dilution of 1:2000 in 1% non-fat milk serum at RT for 1 hr. Detection
Brain, spleen, and spinal cord from selected mice were fixed with was accomplished with an alkaline-phosphatase conjugated goat-
4% buffered formalin, inactivated 1 hr with 98% formic acid, and anti-mouse antibody (1:2000). Visualization was achieved with ni-
embedded in paraffin. Sections were cut to a thickness of 5 m. troblue-tetrazolium and bromo-chloro-indolyl-phosphate according
Selected sections were cut in stages of 100m until the dorsal motor to the protocols of the supplier.
nucleus of the vagal nerve could be identified. For cryosectioning,
tissues were snap-frozen in cryoprotectant compound and cut with
FACS Analysis and Cell Countsa cryostat to a thickness of 6 m. Floating sections were prepared
Blood samples were obtained from the retrobulbar plexus of ether-by immersing tissues in 2% buffered formalin and transferring them
anesthetized mice, and cell blood counts were determined in ato 30% sucrose in 0.1 M phosphate buffer overnight. Floating sec-
hemocytometer (Advia, Boehringer Mannheim, Germany). Single-tions were cut to a thickness of 30 m. Sections were subjected to
cell suspensions of spleen and blood samples, respectively, wereroutine stainings with hematoxylin-eosin and to immunostaining for
prepared at 4
C in buffer solution (PBS containing 2% FCS andglial fibrillary acidic protein (GFAP) according to standard proce-
0.2% NaN3) and stained with the following antibodies: fluoresceindures. Gliosis (a nonspecific but early indicator of brain damage)
isothiocyanate (FITC)-labeled anti-CD11b, phycoerythrin (PE), orwas visualized by the presence of large immunostained reactive
FITC-labeled anti-CD45R/B220, FITC-labeled anti-CD4, PE-labeledastrocytes. In addition, we performed immunostainings for TH. After
anti-CD8b.2, and PE-labeled anti-CD90.2 (Thy1.2) (all Pharmingen).blocking in 4% goat serum, floating sections were incubated over-
After lysis of erythrocytes with FACS lysis solution (Becton Dickin-night with a polyclonal anti-TH antibody (1:5000, Chemicon), washed,
son, San Jose, California) and washing, cell suspensions were ana-and incubated with a biotinylated secondary antibody (1:5000 goat
lyzed on a FACSCalibur (Becton Dickinson). Viable cells were gatedanti rabbit, Vector). Visualization was accomplished with the avidin-
by forward and side scatter of light. Data were acquired with Cell-biotin method using nickel-enhanced DAB. For immunofluorescence,
Quest software (Becton Dickinson); analyses were performed withFITC- or rhodamine-labeled secondary antibodies were used (Sigma,
WinMDI software.Molecular Probes). To detect FDCs, we used monoclonal antibody
FDC-M1 (1:300 clone 4C11). Sections were incubated with a second-
ary antibody (Caltag) and labeling visualized by the alkaline phos- Acknowledgments
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